268 related articles for article (PubMed ID: 21361869)
1. Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.
Ferraris DV; Tsukamoto T
Curr Pharm Des; 2011; 17(2):103-11. PubMed ID: 21361869
[TBL] [Abstract][Full Text] [Related]
2. Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.
Szilágyi B; Ferenczy GG; Keserű GM
Expert Opin Drug Discov; 2018 Oct; 13(10):973-982. PubMed ID: 30220232
[TBL] [Abstract][Full Text] [Related]
3. D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.
Sacchi S; Rosini E; Pollegioni L; Molla G
Curr Pharm Des; 2013; 19(14):2499-511. PubMed ID: 23116391
[TBL] [Abstract][Full Text] [Related]
4. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.
Sershen H; Hashim A; Dunlop DS; Suckow RF; Cooper TB; Javitt DC
Neurochem Res; 2016 Feb; 41(1-2):398-408. PubMed ID: 26857796
[TBL] [Abstract][Full Text] [Related]
5. Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.
Strick CA; Li C; Scott L; Harvey B; Hajós M; Steyn SJ; Piotrowski MA; James LC; Downs JT; Rago B; Becker SL; El-Kattan A; Xu Y; Ganong AH; Tingley FD; Ramirez AD; Seymour PA; Guanowsky V; Majchrzak MJ; Fox CB; Schmidt CJ; Duplantier AJ
Neuropharmacology; 2011; 61(5-6):1001-15. PubMed ID: 21763704
[TBL] [Abstract][Full Text] [Related]
6. Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.
Williams M
Biochem Pharmacol; 2009 Dec; 78(11):1360-5. PubMed ID: 19591808
[TBL] [Abstract][Full Text] [Related]
7. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect.
Rojas C; Alt J; Ator NA; Wilmoth H; Rais R; Hin N; DeVivo M; Popiolek M; Tsukamoto T; Slusher BS
J Psychopharmacol; 2016 Sep; 30(9):887-95. PubMed ID: 27287825
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice.
Rais R; Thomas AG; Wozniak K; Wu Y; Jaaro-Peled H; Sawa A; Strick CA; Engle SJ; Brandon NJ; Rojas C; Slusher BS; Tsukamoto T
Drug Metab Dispos; 2012 Nov; 40(11):2067-73. PubMed ID: 22837388
[TBL] [Abstract][Full Text] [Related]
10. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.
Madeira C; Freitas ME; Vargas-Lopes C; Wolosker H; Panizzutti R
Schizophr Res; 2008 Apr; 101(1-3):76-83. PubMed ID: 18378121
[TBL] [Abstract][Full Text] [Related]
11. D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog.
Rojas C; Alt J; Ator NA; Thomas AG; Wu Y; Hin N; Wozniak K; Ferraris D; Rais R; Tsukamoto T; Slusher BS
Neuropsychopharmacology; 2016 May; 41(6):1610-9. PubMed ID: 26471255
[TBL] [Abstract][Full Text] [Related]
12. Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors.
Szilágyi B; Kovács P; Ferenczy GG; Rácz A; Németh K; Visy J; Szabó P; Ilas J; Balogh GT; Monostory K; Vincze I; Tábi T; Szökő É; Keserű GM
Bioorg Med Chem; 2018 May; 26(8):1579-1587. PubMed ID: 29472125
[TBL] [Abstract][Full Text] [Related]
13. Comments on 'The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia'.
Hashimoto K
J Psychopharmacol; 2010 Jul; 24(7):1133-4. PubMed ID: 19939869
[No Abstract] [Full Text] [Related]
14. Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research.
Kuo CY; Lin CH; Lane HY
CNS Drugs; 2022 Nov; 36(11):1143-1153. PubMed ID: 36194364
[TBL] [Abstract][Full Text] [Related]
15. The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia.
Abou El-Magd RM; Park HK; Kawazoe T; Iwana S; Ono K; Chung SP; Miyano M; Yorita K; Sakai T; Fukui K
J Psychopharmacol; 2010 Jul; 24(7):1055-67. PubMed ID: 19329549
[TBL] [Abstract][Full Text] [Related]
16. Factors regulating serine racemase and d-amino acid oxidase expression in the mouse striatum.
Takagi S; Balu DT; Coyle JT
Brain Res; 2021 Jan; 1751():147202. PubMed ID: 33171153
[TBL] [Abstract][Full Text] [Related]
17. Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.
Fradley R; Goetghebeur P; Miller D; Burley R; Almond S; Gruart I Massó A; Delgado García JM; Zhu B; Howley E; Neill JC; Grayson B; Gaskin P; Carlton M; Gray I; Serrats J; Davies CH
Neurochem Res; 2023 Oct; 48(10):3027-3041. PubMed ID: 37289348
[TBL] [Abstract][Full Text] [Related]
18. Determination of D-serine and D-alanine Tissue Levels in the Prefrontal Cortex and Hippocampus of Rats After a Single Dose of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, with Potential Antipsychotic and Antidepressant Properties.
Huang CC; Wei IH; Yang HT; Lane HY
Neurochem Res; 2023 Jul; 48(7):2066-2076. PubMed ID: 36786942
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
Yang CR; Svensson KA
Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.
Adage T; Trillat AC; Quattropani A; Perrin D; Cavarec L; Shaw J; Guerassimenko O; Giachetti C; Gréco B; Chumakov I; Halazy S; Roach A; Zaratin P
Eur Neuropsychopharmacol; 2008 Mar; 18(3):200-14. PubMed ID: 17681761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]